3
Registered trials
2
Recruiting
2
Unique sponsors
3
Unique IMPs
3
Commercial trials
Drug classes (ATC)
N
Neurology/Psychiatry (ATC N)
2
—
ATC code not specified
1
Mechanism of action (INN-stem analysis)
Unknown / small molecule
3 substances
Phase II/III:
2
Phase I (First in Human):
1
Phase II/III
2 trials-
Not authorisedBicycletx Limited CommercialBT8009
-
RecruitingBicycletx Limited CommercialZELENECTIDE PEVEDOTIN
Phase I (First in Human)
1 trial-
RecruitingBioNTech SE CommercialBNT329
Sponsor activity
| Sponsor | Type | Trials | Phases | Recruiting |
|---|---|---|---|---|
| Bicycletx Limited | Commercial | 2 | Phase II/III | 1 |
| BioNTech SE | Commercial | 1 | Phase I (First in Human) | 1 |
New trials by year
2024
1
2026
1